We are building a strong, global diverse team combining scientific, clinical, commercial experience with a common passion for improving health and wellness
Dr Bruce K Young
Chief Science Officer
Chairman of the Board
Dr. Bruce Young is an internationally recognized leader and innovator in Obstetrics and Gynecology. He founded the Prenatal Diagnosis program at NYU and the Division of Maternal-Fetal Medicine in the 1970s, and has since pioneered a number of areas, most recently amniotic fluid stem cell therapy. He is committed to continue to drive innovation that improves medical care and especially areas of unmet medical need.
Helen Ljungdahl Round
Chief Executive Officer
Helen Ljungdahl Round is a global, results driven and motivational business executive and team leader. She has more than 25 years experience in successfully leading and developing pharmaceutical and medical device businesses in Europe, North America, Latin America, Middle East/Africa, and Asia. She is highly committed to translating science to meet unmet medical and wellness needs while driving profitable growth.
Chief Information Officer
Caroline Einaugler serves as AMNICELL’s Chief Information Officer with a focus on operations. In her position she oversees information management, information assurance and website activities management and operations. She has held several leadership roles in information management in both the medical and health environments. She is experienced in the planning, development, delivery, and monitoring of technical solutions.
Building an innovative diverse team
At AMNICELL, we are deeply committed to our vision of improving lives through advanced stem cell technology using pluripotent human amniotic fluid stem cells. We know what it takes to be excellent, and we are building an outstanding team to bring a novel transformative stem cell technology to patients.
We will be recruiting people who are inspired by science, care about patient outcomes, and aspire to make a difference.